Picrasidine I

Picrasidine I
Product Name Picrasidine I
CAS No.: 100234-59-1
Catalog No.: CFN99019
Molecular Formula: C14H12N2O2
Molecular Weight: 240.3 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Yellow powder
Targets: MAPK | NF-κB | ROS | c-Fos | NFATc1
Source: The barks of Picrasma quassioides.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $368/5mg
Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-κB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Chemistry of Plant Raw Materials2019, 4:135-147
  • Pharmacognosy Magazine2018, 14(56):418-424
  • Tea Res. Ins. Of China2017, 1-12
  • Chemistry of Natural Compounds2019, 55(1):127-130
  • BMC Complement Altern Med.2019, 19(1):325
  • Mol Microbiol.2019, 112(1):317-332
  • J Nat Sc Biol Med2019, 10(2):149-156
  • Nutrients.2019, 11(4):E936
  • Arch Toxicol.2017, 91(10):3225-3245
  • PLoS One.2017, 12(8):e0181191
  • 1-Acetyl-beta-carboline

    Catalog No: CFN92122
    CAS No: 50892-83-6
    Price: Inquiry(manager@chemfaces.com)
    1-Methoxycarbonyl-beta-carboline

    Catalog No: CFN98456
    CAS No: 3464-66-2
    Price: $288/5mg
    1-Methoxycarbonyl-beta-carboline-N-oxide

    Catalog No: CFN95023
    CAS No: 74690-74-7
    Price: $413/5mg
    1-Ethoxycarbonyl-beta-carboline

    Catalog No: CFN92123
    CAS No: 72755-19-2
    Price: Inquiry(manager@chemfaces.com)
    4-Hydroxy-1-methoxycarbonyl-beta-carboline

    Catalog No: CFN92929
    CAS No: 74690-72-5
    Price: Inquiry(manager@chemfaces.com)
    4-Methoxy-1-methoxycarbonyl-beta-carboline

    Catalog No: CFN97037
    CAS No: 60807-25-2
    Price: Inquiry(manager@chemfaces.com)
    Crenatine

    Catalog No: CFN98313
    CAS No: 26585-14-8
    Price: Inquiry(manager@chemfaces.com)
    Picrasidine I

    Catalog No: CFN99019
    CAS No: 100234-59-1
    Price: $368/5mg
    Picrasidine J

    Catalog No: CFN99020
    CAS No: 100234-62-6
    Price: Inquiry(manager@chemfaces.com)
    Dehydrocrenatidine

    Catalog No: CFN97116
    CAS No: 65236-62-6
    Price: Inquiry(manager@chemfaces.com)
    Cellular Physiology & Biochemistry, 2017:1425-1435.
    Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production.[Reference: WebLink]
    Osteoporosis is a metabolic bone disorder that tortures about millions of people worldwide. Recent study demonstrated agents derived from picrasma quassioides is a promising drug for targets multiple signaling pathways. However its potential in treatment of bone loss has not been fully understood.
    METHODS AND RESULTS:
    The bone marrow macrophages (BMMs) were cultured and induced with M-CSF and RANKL followed by Picrasidine I (PI) treatment. Then the effects of PI on osteoclast formation were evaluated by counting tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells. Moreover, effects of PI on bone resorption activity of mature osteoclast were studied through bone resorption pit counting and actin ring structure analysis. Further, the involved potential signaling pathways cross-talking were investigated by performed Western blotting and quantitative real-time PCR examination. Results demonstrated PI strongly inhibited RANKL induced osteoclast formation from its precursors. Mechanistically, the inhibitory effect of PI on osteoclast differentiation was due to the suppression of osteoclastogenic transcription factors, c-Fos and NFATc1. Moreover, PI markedly blocked the RANKL-induced osteoclastogenesis by attenuating MAPKs and NF-κB signaling pathways. In addition, PI decreased the ROS generation in osteoclast and osteoblast.
    CONCLUSIONS:
    Taken together our data demonstrate that PI has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, NF-κB and ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.
    Ganodermanontriol

    Catalog No: CFN99077
    CAS No: 106518-63-2
    Price: $413/5mg
    Balanophonin

    Catalog No: CFN99295
    CAS No: 118916-57-7
    Price: $388/5mg
    Oroxylin A

    Catalog No: CFN98540
    CAS No: 480-11-5
    Price: $138/20mg
    Pinoresinol 4-O-beta-D-glucopyranoside

    Catalog No: CFN97180
    CAS No: 69251-96-3
    Price: $298/20mg
    Ginsenoside Rg6

    Catalog No: CFN90565
    CAS No: 147419-93-0
    Price: $488/10mg
    Epimedoside A

    Catalog No: CFN90762
    CAS No: 39012-04-9
    Price: $198/10mg
    1-Methoxyphaseollidin

    Catalog No: CFN96878
    CAS No: 65428-13-9
    Price: $413/5mg
    Lappaol C

    Catalog No: CFN95068
    CAS No: 64855-00-1
    Price: $333/10mg
    Bryonamide B

    Catalog No: CFN91057
    CAS No: 5942-25-6
    Price: $218/5mg
    Isocarlinoside

    Catalog No: CFN95092
    CAS No: 83151-90-0
    Price: $398/5mg